 | Cardiff Oncology, Inc. | |||
| NCM : CRDF || Location: United States | ||||
$4.17-0.19 (-4.36%) |
0.7 M | 4.06 - 4.42 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.411 M |
| March 15, 2024 | 2.813 M |
| Feb. 29, 2024 | 1.155 M |
| Feb. 15, 2024 | 1.187 M |
| Jan. 31, 2024 | 1.291 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.28 | -0.21 | 25.82% |
| 09/30/2023 | -0.29 | -0.22 | 24.32% |
| 06/30/2023 | -0.26 | -0.25 | 5.45% |
| 03/31/2023 | -0.23 | -0.25 | -8.46% |
| 12/31/2022 | -0.24 | -0.20 | 16.56% |
CRDF Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 44.677M | Shares Float | 41.292M |
| Short Float | 3.411M | Market Cap | 186.30M |
| Institution ownership | 15.20% | Insider ownership | 7.557% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.93 | Forward EPS | -1.06 |